Photo via ABC News (AU)

How a breast cancer trial changed the lives of survivors

Read the original at ABC News (AU) ↗
Cite

Roberts, L. (2026, October 1). How a breast cancer trial changed the lives of survivors. ABC News (AU). https://www.abc.net.au/news/health/2026-10-01/her2-positive-breast-cancer-targeted-drug-pbs/107175438

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

ABC News (AU) · collected 2026-10-01 · by Lauren Roberts

Quick Summary

Donna Rullo, diagnosed with HER2-positive breast cancer in 2001, joined a groundbreaking drug trial for trastuzumab after hearing about it from Dr. Richard Bell. The trial, which included over 5,000 patients across 39 countries, demonstrated that taking the drug significantly improves long-term survival rates. Before its inclusion on Australia's Pharmaceutical Benefits Scheme in 2001, women not enrolled in trials had to pay between $50,000 and $70,000 annually for treatment. The article highlights how the drug trial changed Rullo’s life and made trastuzumab accessible to thousands of breast cancer patients in Australia.
Written by AI on 2026-10-01, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

In early 2001, Donna Rullo, a then-40-year-old Australian woman from a regional fruit farm, was diagnosed with HER2-positive breast cancer. Up to one in five cases of breast cancer are HER2-positive, characterized by higher levels of the HER2 protein and an aggressive growth pattern. At that time, targeted treatments were not available in Australia. Determined to fight her diagnosis, Rullo joined a drug trial for trastuzumab, now known as Herceptin, led by retired oncologist Richard Bell. She drove five hours from her home to Melbourne and participated in the HERA (HERceptin Adjuvant) trial, which eventually enrolled more than 5,000 patients from 39 countries. The drug significantly extended lives for women with HER2-positive breast cancer, often enabling them to watch their children grow up despite selling assets like houses to afford it outside the Pharmaceutical Benefits Scheme.

Written for “Breast Cancer Trial Impact” on 2026-11-02, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Breast Cancer Trial Impact
Health · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
39
sentences that state something as happening or true
Uncertain
5%
2 of 39 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
68/100
ABC News (AU)'s corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-01 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

ABC News (AU) · 4574 article(s) · 10 correction(s) detected
Running correction rate · 10 correction(s)

Who wrote this

Lauren Roberts
5 article(s) here · 1 carrying a prediction
🔮 Researchers believe more targeted treatments will improve outcomes for people with circadian depression.
🔮 "Looking at family history of other cancers, breast screening, cervical screening and having that conversation around chronic conditions." How do the guidelines work? The guidelines list a range of possible treatment options for different menopausal symptoms, including menopausal hormone therapy (MHT), acupuncture and hypnosis, ranking available evidence on a scale of very low to high. The guidelines recommend that women taking MHT have an annual review with their doctor. But there's not enough evidence that weight loss or physical activity alone will improve hot flushes or night sweats, or that hypnosis will improve sleep. Dr Melville, a specialist gynaecologist and sub-specialist in sexual and reproductive health, said the new guidelines would hopefully make it easier for clinicians and patients to understand their options. For example, women with a history of breast cancer can be offered vaginal oestrogen to ease menopausal symptoms. Although RANZCOG had previously released statements about managing menopausal symptoms, Dr Melville said these were their first evidence-based guidelines. How will it improve patient care? Women should receive the same standardised recommendations no matter who they see or where they live if clinicians across Australia use the same guidelines. Jean Hailes for Women's Health chief executive Sarah White, who was not involved with the guidelines, said this was important because clinicians wanted to give their patients the very best support, but there was a lot of online misinformation to wade through.
🔮 "If a man shows up with microscopic, that is, invisible blood in the urine, or visible blood in the urine, we would immediately advance that person to further investigations," she said.
2026-10-10 · assertive framing · Bladder cancer frequently misdiagnosed as UTIs in women
🔮 Dr Zwickl said given the relatively small percentage of trans and gender-diverse people living in Australia, their cohort of 807 was a representative sample and they would expect similar results in a larger cohort.
2026-10-04 · assertive framing · Study links anti-trans content to worse mental health
🔮 I couldn't stop.
Also by Lauren Roberts
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

Australia Australian Breast Cancer Network Melbourne the Pharmaceutical Benefits Scheme

Subjects

Rullo PERSON · 6× Australia GPE · 4× Boyle PERSON · 2× Breast Cancer Network ORG · 2× PBS ORG · 2× Swinburne PERSON · 2× Donna Rullo PERSON · 1× Melbourne GPE · 1× Richard PERSON · 1× Richard Bell PERSON · 1×

Narrative

"I was hearing from women who were selling their houses, selling their holiday houses, selling their farms to try and get this drug," Ms Swinburne says. "Probably knowing it wasn't going to save their lives necessarily, but it was going to extend their lives, and especially when you've got young children, that's really, really important."
framing: assertive · carried by 1 article(s) · first seen 2026-10-01
🔮 I couldn't stop.
2026-10-01 · ABC News (AU)
How a breast cancer trial changed the lives of survivors · assertive framing

Claims (39 extracted, 2 hedged)

Donna Rullo wasn't going down without a fight. asserted
Rullo → go → fight
It was early 2001, and then-40-year-old Ms Rullo had just been diagnosed with HER2-positive breast cancer. asserted
Rullo → diagnose → cancer
Up to one in five cases of breast cancer are HER2-positive, which means the cancer cells have higher than normal levels of human epidermal growth factor 2 (HER2) protein, promoting growth of the cancer itself. asserted
cells → mean → cancer
It's an aggressive and fast-growing cancer, but typically responds well to targeted treatments. asserted
It → grow → treatments
When Ms Rullo was diagnosed, targeted treatments weren't an option in Australia. asserted
treatments → diagnose → Australia
But 25 years ago, she took a leap of faith and joined a drug trial that changed the course of her life, and that of countless women after her. asserted
that → take → her
When Ms Rullo heard about now-retired oncologist Richard Bell's involvement with a trial for a new drug called trastuzumab, she drove five hours from her regional fruit farm to Melbourne for one of his lectures. asserted
she → hear → lectures
Ms Rullo says she rang him once a week before securing a position on the HERA (HERceptin Adjuvant) trial, which went on to enrol more than 5,000 patients from 39 countries. asserted
which → say → countries
She recalls being motivated to watch her son, now 37, grow up. "I went through 10 years of IVF to have him, my son's 12 and he needs me and I want to be here," she says. asserted
she → recall → me
She still remembers getting the call. asserted
She → remember → call
"He said: 'It's Richard, I just wanted to tell you, you're patient number one of the HERA trial,'" she says. asserted
she → say → trial
"I just cried and cried. asserted
I → cry → ?
I couldn't stop. asserted
I → stop → ?
The trial went on to show that taking the drug trastuzumab for a year "significantly improves long-term disease-free survival" for patients with HER2-positive early breast cancer. asserted
taking → go → cancer
"It was the first drug that really showed promise and women were just thinking: 'Oh my God, finally we have something we can all hold onto,'" Ms Rullo says. asserted
Rullo → show → something
The drug with a $50K price tag Twenty years ago today, trastuzumab was added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of patients with HER-2 positive early-stage breast cancer. asserted
trastuzumab → add → cancer
It's a move which Breast Cancer Network Australia founder and then-chief executive Lyn Swinburne says has been "life-changing" for thousands of Australian women since. asserted
Swinburne → say → women
Trastuzumab is now the most common HER2-targeted therapy offered to patients in Australia and New Zealand. asserted
Trastuzumab → target → Australia
It may be given alongside surgery, chemotherapy, radiation or other HER2-targeted treatments, and works by attaching itself to the cancer cell HER2 receptor. uncertain
It → give → receptor
Before its inclusion on the PBS, women not on trials like Ms Rullo were paying between $50,000 and $70,000 a year for treatment, or went without. asserted
women → pay → treatment
It was an accessibility gap that Ms Swinburne and then-Breast Cancer Network Australia board member, breast cancer survivor and former Olympian Raelene Boyle wanted to address. asserted
Swinburne → want → that
"I was hearing from women who were selling their houses, selling their holiday houses, selling their farms to try and get this drug," Ms Swinburne says. "Probably knowing it wasn't going to save their lives necessarily, but it was going to extend their lives, and especially when you've got young children, that's really, really important." asserted
that → hear → children
In June 2001, they invited prime minister John Howard to Ms Boyle's 50th birthday, sitting him between them as they lobbied for the drug to be subsidised. asserted
drug → invite → them
"We basically talked to him all night about this drug and the difference it made," Ms Boyle recalls. asserted
Boyle → talk → drug
In late 2001, the government announced a special program which allowed women with HER-2 positive metastatic breast cancer to access the drug for free. asserted
women → announce → drug
Then, on October 1, 2006, it was added to the PBS for the treatment of patients with HER-2 positive early-stage breast cancer. asserted
it → add → cancer
Breast cancer is very common in Australia, with one in seven women diagnosed with the disease over their lifetime. asserted
women → diagnose → lifetime
Although more people in Australia are being diagnosed with breast cancer each year, Breast Cancer Network Australia chief executive Kirsten Pilatti says survivors are also living longer than ever before. asserted
survivors → diagnose → cancer
"Survival has certainly improved because we know more about the specifics of different breast cancers," she says. asserted
she → improve → cancers
In 2017–2021, the chance of surviving at least five years post-diagnosis was 93 per cent, up from 75 per cent in 1987–1991. asserted
chance → survive → 1987–1991
Rachel Dear, a medical oncologist at St Vincent's Hospital in Sydney, says improved survival rates have been driven by earlier detection and diagnosis, improved awareness and "more personalised and targeted" treatments. asserted
rates → say → detection
Understanding more about how different types of cancer behave and respond to treatment allows specialists to tailor treatments to each patient, Dr Dear says. asserted
Dear → understand → patient
"Treatment has changed depending on which subtype of breast cancer we're looking at," she says. asserted
she → change → cancer
"There are three main types of breast cancer, and within each of those three types, there are more drug treatment options that have improved survival rates. asserted
that → be → rates
"In 2026, we have a number of new drug treatments to offer patients." asserted
we → have → patients
Breast cancer's huge public profile means there is greater awareness of the disease, Dr Dear says, but has also led to greater investment in research and clinical trials, resulting in more treatment options for patients. asserted
Dear → mean → patients
Ms Rullo considers herself lucky to have seen her son grow into a "remarkable" man, marry and have two kids of his own. asserted
son → consider → own
She encourages people facing an uncertain health diagnosis to learn as much as they can and to advocate for themselves, if needed. asserted
they → encourage → themselves
"Life could have completely gone a different way, who knows what could have happened if I didn't fight to be on that trial," she says. uncertain
she → go → trial
💬Give feedback
🕘History 🎫Support